Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385667697> ?p ?o ?g. }
- W4385667697 endingPage "e3331772" @default.
- W4385667697 startingPage "e3331772" @default.
- W4385667697 abstract "Topic: 35. Quality of life and palliative care Background: Medical care is shifting from a disease-centered approach to a more personalized one. Patient-reported outcome measurement(PROM)are reports of health status or quality of life (QoL) directly provided by patients. They are routinely captured within clinical trials and are slowly being incorporated in the daily standard of care in patients with hematological diseases. “E-Res” is a value-based healthcare program implemented in a four-public hospitals network in Spain that aims to improve process management and patient journey giving voice to patients by collecting individual and aggregated data. Aims: The hypothesis of this prospective multi-center study was that the implementation of an electronic PRO measurement(ePROM)program in patients with lymphoma receiving intravenous(iv)chemotherapy in the outpatient setting may improve self-perception of health,allow a better use of resources, and have positive impact on survival. Methods: Patients with diagnosis of any type of lymphoma in the need of iv therapy between January 1st, 2020, and June 30th, 2022, in a four-public hospitals network were included in the study. Those patients rejecting participation were considered the control arm. All participating patients were registered in the hospital patient portal app. PRO-CTCAE™ questionnaire was electronically sent through the app at 3 points (after 1st, 3rd and 6th course of therapy). Those patients reporting symptoms of low intensity were to receive recommendations automatically through the app. Those reporting symptoms of high intensity were to receive a teleconsultation call by a specialized nurse. Results: Among the 244 patients included in the study, 121 (49.6%) reported outcomes in the ePROM program. Despite patients were not randomized, baseline characteristic (age, sex, ECOG, diagnosis, treatment and previous lines of therapy) were balanced. Low grade of agreement was met between adverse events (AE) reported by physicians at electronic medical records (EMR) and those reported by patients. The only categories where no differences were found (p>0.05) were gastrointestinal (63% vs. 68%), neurological (29% vs. 31%) and respiratory (12% vs. 17%). Cutaneous, oral and sleep disorders were reported by more than 50% of patients but only at 26, 22 and 19% of EMR (p<0.05). Despite showing tendency, no statistical difference was found between the percentage of patients reporting high grade AE at the 3 different moments. In terms of clinical benefits, those who were adherent to the program had fewer number of visits to the Emergency Room (33.3% vs. 55.7%; p<0.01) and showed a tendency to require fewer unscheduled hospital admissions (21.5% vs. 32.0%; p=0.075). More patients among those included in the ePROM program were able to complete the full initially planned treatment (94.2% vs. 83.6%; p<0.05). Finally, after a median follow-up of 18.8 months (IQR 11.3-23.2), median overall survival (OS) was not reached in either group, but it was significantly longer among patients included in “E-Res Salud” program than among those who were not (88.2% vs. 79.7% after 18 months of follow up; stratified hazard ratio, 2.25; 95% confidence interval [CI], 1.23 to 4.13;p=0.007 by a two-sided log-rank test)(Figure 1). Summary/Conclusion: Better understanding of patient-reported symptoms could aid physicians to develop an individualized treatment plan and having an early feed-back seems to improve self-perception of health. The inclusion in the program and the reduction of ER visits has an impact in survival and both direct and indirect costs. Further follow-up and larger sample size will allow us to increase the level of detail and will lead to a decision-making process by integrating patient voice into healthcare decision.Keywords: Lymphoma, Quality of life" @default.
- W4385667697 created "2023-08-09" @default.
- W4385667697 creator A5000853686 @default.
- W4385667697 creator A5003747097 @default.
- W4385667697 creator A5005556458 @default.
- W4385667697 creator A5006284336 @default.
- W4385667697 creator A5009740721 @default.
- W4385667697 creator A5012222456 @default.
- W4385667697 creator A5016898720 @default.
- W4385667697 creator A5018452619 @default.
- W4385667697 creator A5019430119 @default.
- W4385667697 creator A5031413184 @default.
- W4385667697 creator A5032020190 @default.
- W4385667697 creator A5033766995 @default.
- W4385667697 creator A5037167222 @default.
- W4385667697 creator A5042423121 @default.
- W4385667697 creator A5045287931 @default.
- W4385667697 creator A5045437015 @default.
- W4385667697 creator A5067760286 @default.
- W4385667697 creator A5072880316 @default.
- W4385667697 creator A5074540960 @default.
- W4385667697 creator A5077730260 @default.
- W4385667697 creator A5080971880 @default.
- W4385667697 creator A5084078618 @default.
- W4385667697 creator A5086718322 @default.
- W4385667697 creator A5091114444 @default.
- W4385667697 date "2023-08-01" @default.
- W4385667697 modified "2023-10-18" @default.
- W4385667697 title "P1689: REAL-WORLD EVIDENCE OF USING TELEMEDICINE TO CAPTURE ELECTRONIC PROM IMPROVES QUALITY OF LIFE ASSESSMENT, HEALTHCARE RESOURCES MANAGEMENT AND OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA" @default.
- W4385667697 doi "https://doi.org/10.1097/01.hs9.0000973628.33317.72" @default.
- W4385667697 hasPublicationYear "2023" @default.
- W4385667697 type Work @default.
- W4385667697 citedByCount "0" @default.
- W4385667697 crossrefType "journal-article" @default.
- W4385667697 hasAuthorship W4385667697A5000853686 @default.
- W4385667697 hasAuthorship W4385667697A5003747097 @default.
- W4385667697 hasAuthorship W4385667697A5005556458 @default.
- W4385667697 hasAuthorship W4385667697A5006284336 @default.
- W4385667697 hasAuthorship W4385667697A5009740721 @default.
- W4385667697 hasAuthorship W4385667697A5012222456 @default.
- W4385667697 hasAuthorship W4385667697A5016898720 @default.
- W4385667697 hasAuthorship W4385667697A5018452619 @default.
- W4385667697 hasAuthorship W4385667697A5019430119 @default.
- W4385667697 hasAuthorship W4385667697A5031413184 @default.
- W4385667697 hasAuthorship W4385667697A5032020190 @default.
- W4385667697 hasAuthorship W4385667697A5033766995 @default.
- W4385667697 hasAuthorship W4385667697A5037167222 @default.
- W4385667697 hasAuthorship W4385667697A5042423121 @default.
- W4385667697 hasAuthorship W4385667697A5045287931 @default.
- W4385667697 hasAuthorship W4385667697A5045437015 @default.
- W4385667697 hasAuthorship W4385667697A5067760286 @default.
- W4385667697 hasAuthorship W4385667697A5072880316 @default.
- W4385667697 hasAuthorship W4385667697A5074540960 @default.
- W4385667697 hasAuthorship W4385667697A5077730260 @default.
- W4385667697 hasAuthorship W4385667697A5080971880 @default.
- W4385667697 hasAuthorship W4385667697A5084078618 @default.
- W4385667697 hasAuthorship W4385667697A5086718322 @default.
- W4385667697 hasAuthorship W4385667697A5091114444 @default.
- W4385667697 hasBestOaLocation W43856676971 @default.
- W4385667697 hasConcept C131872663 @default.
- W4385667697 hasConcept C159110408 @default.
- W4385667697 hasConcept C160735492 @default.
- W4385667697 hasConcept C162324750 @default.
- W4385667697 hasConcept C1862650 @default.
- W4385667697 hasConcept C2777364248 @default.
- W4385667697 hasConcept C2779891985 @default.
- W4385667697 hasConcept C2779951463 @default.
- W4385667697 hasConcept C2994186709 @default.
- W4385667697 hasConcept C50522688 @default.
- W4385667697 hasConcept C512399662 @default.
- W4385667697 hasConcept C545542383 @default.
- W4385667697 hasConcept C71924100 @default.
- W4385667697 hasConceptScore W4385667697C131872663 @default.
- W4385667697 hasConceptScore W4385667697C159110408 @default.
- W4385667697 hasConceptScore W4385667697C160735492 @default.
- W4385667697 hasConceptScore W4385667697C162324750 @default.
- W4385667697 hasConceptScore W4385667697C1862650 @default.
- W4385667697 hasConceptScore W4385667697C2777364248 @default.
- W4385667697 hasConceptScore W4385667697C2779891985 @default.
- W4385667697 hasConceptScore W4385667697C2779951463 @default.
- W4385667697 hasConceptScore W4385667697C2994186709 @default.
- W4385667697 hasConceptScore W4385667697C50522688 @default.
- W4385667697 hasConceptScore W4385667697C512399662 @default.
- W4385667697 hasConceptScore W4385667697C545542383 @default.
- W4385667697 hasConceptScore W4385667697C71924100 @default.
- W4385667697 hasIssue "S3" @default.
- W4385667697 hasLocation W43856676971 @default.
- W4385667697 hasLocation W43856676972 @default.
- W4385667697 hasOpenAccess W4385667697 @default.
- W4385667697 hasPrimaryLocation W43856676971 @default.
- W4385667697 hasRelatedWork W2033565280 @default.
- W4385667697 hasRelatedWork W2341390217 @default.
- W4385667697 hasRelatedWork W2541239117 @default.
- W4385667697 hasRelatedWork W2606895318 @default.
- W4385667697 hasRelatedWork W2782234760 @default.
- W4385667697 hasRelatedWork W2908319631 @default.
- W4385667697 hasRelatedWork W2911727177 @default.
- W4385667697 hasRelatedWork W3019894189 @default.